Clinical Trial Update: Vaccine Therapy and Resiquimod in Treating Patients With Stage II, Stage III, or Stage IV Melanoma That Has Been Completely Removed by Surgery [EARLY_Phase 1]

View source ↗

Summary

An early-phase clinical trial evaluating the combination of a vaccine therapy with resiquimod as adjuvant treatment in patients with surgically resected stage I…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Resiquimod (resiquimod)
• Vaccine therapy

Snippet

Sponsor: Mayo Clinic | Conditions: Melanoma (Skin) | EARLY_Phase 1 | Status: COMPLETED